科瑞產(chǎn)品

- 客戶定制產(chǎn)品 - 前列腺素系列 - PI3K Inhibitors - C-Kit Inhibitors - VEGFR Inhibitors - mTOR Inhibitors - c-Met Inhibitors - DNA/RNA Inhibitors - HER2 Inhibitors - Raf Inhibitors - JAK Inhibitors - Others - SRC Inhibitors - AKT Inhibitors - CDK Inhibitors

浙江省臺(tái)州市椒江開(kāi)發(fā)大道東段288號(hào)萬(wàn)達(dá)廣場(chǎng)2號(hào)樓

0576-88813233

0576-88670057

sales@crene.cn

合作客戶/Partner

當(dāng)前位置：科瑞產(chǎn)品

阿巴帕肽 Abaloparatide

規(guī)格	價(jià)格	庫(kù)存	數(shù)量
在線咨詢大包裝詢價(jià) 加入購(gòu)物車

如您需要更多數(shù)量的報(bào)價(jià)，請(qǐng)點(diǎn)擊立即獲取報(bào)價(jià)或者通過(guò)電子郵件sales@crene.cn把您需要的數(shù)量信息提交給我們我們會(huì)在第一時(shí)間回復(fù)您，謝謝！

產(chǎn)品信息

產(chǎn)品名稱：阿巴帕肽 Abaloparatide	純度：98% min
CAS NO：247062-33-5	溶解度：
分子式：C₁₇₄H₃₀₀N₅₆O₄₉	包裝：可按客戶要求包裝
分子量：3960.59	貯存：-20℃

質(zhì)量控制

備注說(shuō)明

Abaloparatide (brand name Tymlos) is a parathyroid hormone-related protein (PTHrP) analog drug used to treat osteoporosis. Like the related drug teriparatide, and unlike bisphosphonates, it is an anabolic (i.e., bone growing) agent.

參考文獻(xiàn)

1: Taylor AD, Saag KG. Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy. Core Evid. 2019 Aug 23;14:41-50. doi: 10.2147/CE.S172820. eCollection 2019. PubMed PMID: 31692480; PubMed Central PMCID: PMC6711555.

2: Leder BZ, Mitlak B, Hu MY, Hattersley G, Bockman RS. Effect of Abaloparatide Versus Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis. J Clin Endocrinol Metab. 2019 Nov 1. pii: dgz162. doi: 10.1210/clinem/dgz162. [Epub ahead of print] PubMed PMID: 31674644.